Opinion|Videos|September 25, 2024
Clinical Scenario: Metastatic EBV-Positive NPC
The panel provides clinical insights on the treatment of a patient with metastatic EBV-positive nasopharyngeal carcinoma.
Advertisement
Episodes in this series
Advertisement
Related to this article
Neoadjuvant and adjuvant pembrolizumab improved EFS across surgical outcome subgroups in resectable head and neck squamous cell carcinoma.
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Mezigdomide Plus Kd in R/R Myeloma
2
Dostarlimab Achieves Sustained Clinical Complete Responses in dMMR/MSI-H Rectal Cancer
3
Dive Into Key Data and Presentations From EHA 2026
4
Access, Sequencing Considerations Remain Key Focal Points for CAR T-Cell Therapy in R/R Myeloma
5